Page last updated: 2024-11-02

pioglitazone and Animal Mammary Carcinoma

pioglitazone has been researched along with Animal Mammary Carcinoma in 2 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research Excerpts

ExcerptRelevanceReference
"Pioglitazone was administered in the diet at concentrations of 10 and 100 ppm, respectively, 12 days before the first carcinogen dose until the termination of the experiment."1.36Pioglitazone in chemically induced mammary carcinogenesis in rats. ( Ahlers, I; Ahlersová, E; Bojková, B; Garajová, M; Kajo, K; Kassayová, M; Kisková, T; Kubatka, P; Orendás, P; Péc, M, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Sisi, AE1
Sokar, SS1
Salem, TA1
Abu Risha, SE1
Bojková, B1
Garajová, M1
Kajo, K1
Péc, M1
Kubatka, P1
Kassayová, M1
Kisková, T1
Orendás, P1
Ahlersová, E1
Ahlers, I1

Other Studies

2 other studies available for pioglitazone and Animal Mammary Carcinoma

ArticleYear
PPARγ-dependent anti-tumor and immunomodulatory actions of pioglitazone.
    Journal of immunotoxicology, 2015, Volume: 12, Issue:4

    Topics: Animals; Apoptosis; Carcinoma, Ehrlich Tumor; Doxorubicin; Female; Gene Expression Regulation, Neopl

2015
Pioglitazone in chemically induced mammary carcinogenesis in rats.
    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2010, Volume: 19, Issue:5

    Topics: Animals; Anticarcinogenic Agents; Carcinogens; Dose-Response Relationship, Drug; Female; Mammary Neo

2010